Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites
Authors
Keywords
Pancreatic cancer, Malignant ascites, Peritoneal metastasis, S-1, Paclitaxel, Intraperitoneal chemotherapy
Journal
INVESTIGATIONAL NEW DRUGS
Volume 34, Issue 5, Pages 636-642
Publisher
Springer Nature
Online
2016-06-23
DOI
10.1007/s10637-016-0369-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer
- (2015) M. Ueno et al. ANNALS OF ONCOLOGY
- Linear Relationship of Peritoneal Cancer Index and Survival in Patients with Peritoneal Metastases from Colorectal Cancer
- (2015) Matthieu Faron et al. ANNALS OF SURGICAL ONCOLOGY
- Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer
- (2015) S Ohkawa et al. BRITISH JOURNAL OF CANCER
- Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial
- (2014) Helmut Oettle et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome Data of Patients with Peritoneal Carcinomatosis from Gastric Origin Treated by a Strategy of Bidirectional Chemotherapy Prior to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in a Single Specialized Center in Japan
- (2013) Emel Canbay et al. ANNALS OF SURGICAL ONCOLOGY
- A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis
- (2013) Hironori Yamaguchi et al. CANCER
- A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer
- (2013) Naminatsu Takahara et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
- (2013) Hideki Ueno et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
- (2012) Y Nakai et al. BRITISH JOURNAL OF CANCER
- Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer
- (2012) Naminatsu Takahara et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Incidence, Prognosis, and Possible Treatment Strategies of Peritoneal Carcinomatosis of Pancreatic Origin
- (2012) Irene Thomassen et al. PANCREAS
- A Prognostic Model to Identify Patients with Advanced Pancreas Adenocarcinoma Who Could Benefit from Second-line Chemotherapy
- (2011) Seung Tae Kim et al. CLINICAL ONCOLOGY
- Multicenter Phase II Study of Gemcitabine and S-1 Combination Therapy (GS Therapy) in Patients With Metastatic Pancreatic Cancer
- (2011) H. Ueno et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gemcitabine and Oxaliplatin Combination Chemotherapy for Patients with Refractory Pancreatic Cancer
- (2011) Hiroyuki Isayama et al. ONCOLOGY
- Construction and Validation of a Prognostic Index for Patients With Metastatic Pancreatic Adenocarcinoma
- (2011) Chigusa Morizane et al. PANCREAS
- Impact of S-1 in Patients with Gemcitabine-refractory Pancreatic Cancer in Japan
- (2010) Y. Nakai et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Weekly Paclitaxel After Failure of Gemcitabine in Pancreatic Cancer Patients with Malignant Ascites: A Retrospective Study
- (2010) T. Shukuya et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Impact of S-1 on the Survival of Patients With Advanced Pancreatic Cancer
- (2010) Yousuke Nakai et al. PANCREAS
- Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis
- (2009) H. Ishigami et al. ANNALS OF ONCOLOGY
- Prognostic Impact of RT-PCR-Based Detection of Peritoneal Micrometastases in Patients with Pancreatic Cancer Undergoing Curative Resection
- (2009) Kaitlyn J. Kelly et al. ANNALS OF SURGICAL ONCOLOGY
- A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer
- (2009) C Yoo et al. BRITISH JOURNAL OF CANCER
- Phase I Pharmacokinetic Study of Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Advanced Gastric Cancer
- (2009) Hironori Ishigami et al. ONCOLOGY
- A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer
- (2009) Yousuke Nakai et al. ONCOLOGY
- A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer
- (2008) Chigusa Morizane et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now